Today published at Mail Online is an article by Fiona Roberts reporting on a lawsuit filed by the parents of Myles Massey, who since birth has suffered from brain damage. According to the article the parents believe their child's condition was caused by contaminated alcohol prep pads manufactured by Triad.
Back in February the HCV community was alerted to a recall of the prep pads manufactured by Triads parent company H&P. The prep pads were packaged with pegasys in the U.S . and Pegintron outside the U.S. It was reported that the pads from H&P were potentially contaminated with a rare bacteria, Bacillus cereus.
Just last week MSNBC ran this article "FDA probes new death, infections tied to tainted wipes" .
"Federal health officials are investigating whether contaminated alcohol prep products from a shuttered Wisconsin firm led to the death of a 66-year-old man who developed a bacterial infection after being treated for skin cancer and diabetes.
The death is among eight reports of fatalities, 11 infections and nearly 250 other problems now associated with medical products manufactured and distributed by the Triad Group and H&P Industries Inc. of Hartland, Wis., newly released records from the federal Food and Drug Administration show."
To read all the blog updates on the tainted wipes click here
From Mail Online;
"A newborn baby was left with severe brain damage after he contracted a rare bacterial infection carried by an alcohol wipe, a lawsuit claims.
Myles Massey, now three, cannot speak or walk, has cerebral palsy and must be fed through a stomach tube - yet his twin brother, Henry, developed normally.
The boys' parents, Aaron and Tracy Massey, from Kenmore, Washington, have spent years battling to find out what caused the devastating infection."
Read more
:
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment